Defence Press Releases & Articles 976 - 976 of 976
Proteotech And Tasly Pharmaceuticals Announce Alzheimer's Disease Drug Developme
5th October 2010 -
Views: 1145
Tasly Pharmaceutical Co., Ltd. (Tianjin, China) and ProteoTech, Inc.
(Kirkland, WA, USA) today announced an agreement to co-develop ProteoTech's
novel small molecule therapeutic, Exebryl-1(R), for the treatment of
mild-to-moderate Alzheimer's disease.
NEWS 
